Changes in ANA Testing
Effective Monday, February 25, 2013, the University of Iowa Hospitals and Clinics core clinical chemistry laboratory will begin running some of the anti-nuclear antigen (ANA)-related tests (e.g., double-stranded DNA antibodies, SS-A antibodies) on the Bio-Rad Bioplex 2200 analyzer. Some of these replace existing tests available either in the Immunopathology Laboratory or as mailouts, while several are new tests.
The "ANTI-NUCLEAR ANTIBODY (ANA) SCREEN WITH REFLEX TO TITER BY IFA" (LAB1256) will continue to be the ANA screening method. The screening cutoff for ANA testing will be moved to 1:80 from 1:40 to reduce the number of low level ANA positive results.
First-time positive double-stranded DNA antibody results will be confirmed by Crithidia immunofluorescence at no additional charge as is current practice. Scl-70 antibody will continue to be run in the Immunopathology laboratory.
Details on the tests are as follows:
Test name | Epic # | Specimen* | Laboratory |
Anti-Nuclear Antibody (ANA) screen with reflex titer by IFA | LAB1256 | Red top | Immunopathology |
Centromere B Antibody | LAB7828 | Light green PST** | Core laboratory |
Chromatin Antibody | LAB7827 | Light green PST** | Core laboratory |
Double-stranded DNA Antibody | LAB1299 | Light green PST** | Core laboratory |
JO-1 Antibody | LAB3455 | Light green PST** | Core laboratory |
Ribosomal P Protein | LAB3995 | Light green PST** | Core laboratory |
RNP Antibody | LAB1249 | Light green PST** | Core laboratory |
Scl-70 Antibody | LAB1349 | Red top | Immunopathology |
Sm/RNP (Common Motif) Antibodies | LAB1346 | Light green PST** | Core laboratory |
Smith Antibody | LAB1250 | Light green PST** | Core laboratory |
SS-A Antibody | LAB344 | Light green PST** | Core laboratory |
SS-B Antibody | LAB345 | Light green PST** | Core laboratory |
* 3 mL whole blood or two pediatric microtainers.
** Light green PST (lithium heparin plasma separator tube) is preferred specimen type. However, lavender/pink EDTA and red top tubes can also be used for these tests.
Questions should be directed to Matthew Krasowski, MD, PhD, medical director of the Clinical Chemistry Laboratory (384-9380, matthew-krasowski@uiowa.edu).